medicina59巻13号

2022年12月発行

記事購入ページに移動

特集 令和の頭痛診療—プライマリ・ケア医のためのガイド 頭痛診療のTips＆Topics 〈頭痛診療のTopics〉

COVID-19と頭痛—コロナ感染後・ワクチン接種後の頭痛，コロナ禍における頭痛

著者： 鈴木圭輔¹ 松林賢照¹ 椎名智彦¹

所属機関： ¹獨協医科大学脳神経内科

ページ範囲：P.2466 - P.2469

Point
◎頭痛は新型コロナウイルス感染症（COVID-19）の代表的な神経症状である．
◎ワクチン接種後の頭痛は，発熱や注射部位反応などの副反応のようにしばしばみられる．
◎片頭痛はコロナ禍で悪化する場合があり注意が必要である．

参考文献

1）鈴木圭輔：新型コロナウイルス感染症（COVID-19）と頭痛．臨床神経学60：589-596, 2020

2）Mao L, et al：Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77：683-690, 2020

3）Tostmann A, et al：Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Euro Surveill 25：2000508, 2020

4）Uygun Ö, et al：Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 21：121, 2020

5）Garg M, et al：The conundrum of‘long-COVID-19’；A narrative review. Int J Gen Med 14：2491-2506, 2021

6）Fernandez-de-Las-Penas C, et al：The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue；A case-control study. Cephalalgia 41：1332-1341, 2021

7）Abarca K, et al：Safety and non-inferiority evaluation of two immunization schedules with an inactivated SARS-CoV-2 vaccine in adults；A randomized clinical trial. Vaccines（Basel）10：1082, 2022

8）Ortiz-Prado E, et al：A comparative analysis of a self-reported adverse events analysis after receiving one of the available SARS-CoV-2 vaccine schemes in Ecuador. Vaccines（Basel）10：1047, 2022

9）Dey A, et al：Surveillance of adverse events following immunisation in Australia annual report, 2020. Commun Dis Intell（2018）46, 2022

10）Göbel CH, et al：Headache attributed to vaccination against COVID-19（Coronavirus SARS-CoV-2）with the ChAdOx1 nCoV-19（AZD1222）vaccine；A multicenter observational cohort study. Pain Ther 10：1309-1330, 2021

11）Urakawa R, et al：Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan；A cross-sectional study. BMC Infect Dis 22：179, 2022

12）Göbel CH, et al：Clinical characteristics of headache after vaccination against COVID-19（coronavirus SARS-CoV-2）with the BNT162b2 mRNA vaccine；A multicentre observational cohort study. Brain Commun 3：fcab169, 2021

13）Matsumoto N, et al：Adverse reactions and attitudes toward vaccines among young populations one month after receiving a second dose of mRNA-1273 in Japan. Glob Health Med 4：141-143, 2022

14）Sekiguchi K, et al：Incidence of headache after COVID-19 vaccination in patients with history of headache；A cross-sectional study. Cephalalgia 42：266-272, 2022

15）Silvestro M, et al：Headache worsening after COVID-19 vaccination；An online questionnaire-based study on 841 patients with migraine. J Clin Med 10：5914, 2021

16）Brandt RB, et al：COVID-19 vaccination-triggered cluster headache episodes with frequent attacks. Cephalalgia：3331024221113207, 2022［Online ahead of print］

17）Suzuki K, et al：Impact of the COVID-19 pandemic on migraine in Japan；A multicentre cross-sectional study. J Headache Pain 22：53, 2021

18）Al-Hashel JY, Ismail II：Impact of coronavirus disease 2019（COVID-19）pandemic on patients with migraine；A web-based survey study. J Headache Pain 21：115, 2020

19）Delussi M, et al：Investigating the effects of COVID-19 quarantine in migraine；An observational cross-sectional study from the Italian National Headache Registry（RICe）. Front Neurol 11：597881, 2020

20）Verhagen IE, et al：Effect of lockdown during COVID-19 on migraine；A longitudinal cohort study. Cephalalgia 41：865-870, 2021

21）Ong JJY, et al：Headaches associated with personal protective equipment；A cross-sectional study among frontline healthcare workers during COVID-19. Headache 60：864-877, 2020